JP Patent

JP7425794B2 — 置換されたインダンを含む固体分散体及び医薬組成物並びにそれの製造方法及び使用

Assigned to ペロトン セラピューティクス， インコーポレイテッド · Expires 2024-01-31 · 2y expired

What this patent protects

Patent listed against Welireg.

Drugs covered by this patent

Patent Metadata

Patent number
JP7425794B2
Jurisdiction
JP
Classification
—
Expires
2024-01-31
Drug substance claim
No
Drug product claim
No
Assignee
ペロトン セラピューティクス， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.